While systemic IL-5 production in IL5Tg mice drives the accumulation of eosinophils in the lungs, previous studies have shown that cancer cells and host cells can produce factors which recruit eosinophils to the tumor microenvironment, such as IL-5, CCL11, and various damage-associated molecular patterns (DAMPs). This evidence concerns the gene IL5 and neoplasm.